1. What is the Chemxpert database?

Chemxpert database is a techno-commercial information platform developed and operated by Lifescience Intellipedia Pvt. Ltd. Our data provides valuable insights regarding sourcing, marketing, development, and regulatory functions for the entire Lifescience industry. The different industries covered by our data encompass APIs, FDFs, pharma intermediates, paints, dyes, polymers, biotechnology, biochemical, food additives, nutraceuticals, etc.

2. How can I subscribe to the Chemxpert database?

You can gain access to the Chemxpert database after subscribing to it by visiting this link: - https://chemxpert.com/pricing

3. How many countries' data is available on your portal?

The Chemxpert database covers more than 200 countries. We are working in the direction of expanding our data coverage in more countries.

4. What are the different sources you use for obtaining information?

The different sources we use for data collection are as follows: - • Primary researc • DMF, ANDA, & CEP list • Conferences, Exhibitions, & Tradeshow • Company annual reports • DMF, ANDA, & CEP list • Subject matter experts & KOL survey. Apart from these, our other valuable sources include application-wise manufacturers list, subscribed and non-subscribed databases, corporate partners, US FDA Orange book, publicly available sources, industry associates, national statistics, regulatory websites, etc. You can gain access to the Chemxpert database after subscribing to it by visiting this link: -https://chemxpert.com/sources

5. What is the expected time for account activation?

Your Chemxpert account will be activated instantly if the payment is made through our website. If you choose to use RTGS, NEFT, or IMPS systems for payment, your account will be activated within 24 hours.

20 Jan 2021
Admin
News Article

Cocrystal Pharma Announces Further Development Of Influenza A/B Antiviral Compounds By Merck Under Exclusive Worldwide License And Collaboration Agree

Cocrystal Pharma, Inc., A Clinical-Stage Biotechnology Company Discovering And Developing Novel Antiviral Therapeutics That Target The Replication Machinery Of Influenza Viruses, Sars-Cov-2 Virus, Hepatitis C Viruses And Noroviruses, Announces It Has Completed All Research Obligations Under The Merck Exclusive Worldwide License And Collaboration Agreement, And That Merck Is Now Solely Responsible For Further Development Of The Influenza A/B Antiviral Compounds That Were Discovered Using Cocrystal&Rsquo;S Unique Structure-Based Technologies And Nobel Prize-Winning Expertise.&Ldquo;Through A Highly Productive Relationship With Merck, Teams From Both Companies Worked Collaboratively To Rapidly Advance The Discovery And Initial Development Of Promising Proprietary Influenza A/B Antiviral Compounds,&Rdquo; Said Gary Wilcox, Ph.D., Chairman And Chief Executive Officer Of Cocrystal. &Ldquo;Under The Agreement Announced In January 2019, Merck Had An Option For Cocrystal To Perform Up To 12 Months Of Additional Work If The Initial Two Years Of Collaboration Did Not Progress As Expected. We Are Pleased Our Collaboration Achieved Its Goals Within The Timeline And That There Is No Need For Merck To Exercise The Option. As This Program Advances, Merck Is Now Responsible For Funding Continued Development Of The Compounds.&Rdquo;&Ldquo;Developing New, Effective Influenza Antivirals Represents A Significant Unmet Worldwide Medical Need And Is Integral To Our Infectious Diseases R&Amp;D Strategy,&Rdquo; Said Daria Hazuda, Ph.D., Vice President, Infectious Diseases Discovery, Merck Research Laboratories And Chief Scientific Officer, Merck Exploratory Science Center. &Ldquo;We Are Pleased With The Progress Under Our Collaboration With Cocrystal And Look Forward To Further Development Of The Antiviral Agents In The Influenza A/B Program At Merck

Let’s apply Data-Driven Pricing to Your APIs

Sick and tired of always wondering if you are being asked to pay the right price for your APIs? This empowers you with the answers you need to make the right decisions in the Global API market.

Chemxpert Database is one of the biggest and most comprehensive directories of pharma and chemicals, manufacturers, suppliers and information. Provided with current information on prices, demand and transactions, it gives you instant feedback on whether you are buying what is right and at the right time.

Start using market intelligence today and allow yourself to be in control in the API market.

Check it out today and make more informed sourcing decisions! Learn More!